Expert Committee on Specifications for Pharmaceutical Preparations
The development of norms, standards and guidelines to promote quality assurance and quality control is an integral part of WHO’s Constitution and a unique responsibility. It has been endorsed and supported through numerous World Health Assembly resolutions, and more recently in those on the Revised Drug Strategy.
A large number of guidelines relating to quality assurance has been prepared in consultation with the WHO Expert Advisory Panel on The International Pharmacopoeia and Pharmaceutical Preparations, with specialists from industry, national institutions, NGOs, etc, usually by a vast consultative procedure. The draft guidelines are evaluated during the WHO Expert Committee on Specifications for Pharmaceutical Preparations and if found suitable adopted as international standards. This Committee meets every year and each report (WHO Technical Report Series) includes all adopted guidelines in the form of Annexes.
WHO Expert Committee on Specifications for Pharmaceutical Preparations: Outcome of 44 meetings
The main points addressed in this short summary are the basics of all the World Health Organization (WHO) Expert Committees. Addressed specifically will be the WHO Expert Committee on Specifications for Pharmaceutical Preparations together with the outcome and recommendations of its 44 meetings and their conclusions.
